scholarly journals Non-pharmacological treatment of psychiatric disorders in individuals with 22q11.2 deletion syndrome; a systematic review

2018 ◽  
Vol 176 (8) ◽  
pp. 1742-1747 ◽  
Author(s):  
Petra C. M. Buijs ◽  
Anne S. Bassett ◽  
Erik Boot
Keyword(s):  
Systematic Review ◽  
Psychiatric Disorders ◽  
Pharmacological Treatment ◽  
22Q11.2 Deletion Syndrome ◽  
Deletion Syndrome ◽  
22Q11.2 Deletion

Antipsychotic Treatment of 22q11.2 Deletion Syndrome-Related Psychoses

2017 ◽  
Vol 50 (04) ◽  
pp. 162-163 ◽  
Author(s):  
Elias Angelopoulos ◽  
Christos Theleritis ◽  
Marina Economou ◽  
Korina Georgatou ◽  
Charalambos Papageorgiou ◽  
...  
Keyword(s):  
Antipsychotic Medication ◽  
Combination Treatment ◽  
Pharmacological Treatment ◽  
22Q11.2 Deletion Syndrome ◽  
Deletion Syndrome ◽  
Antipsychotic Treatment ◽  
Treatment Resistant ◽  
22Q11.2 Deletion ◽  
Recent Letter ◽  
Letter To The Editor

AbstractIn the recent study by Verhoeven and Egger, 2015 and the recent letter to the editor by Boot et al. 2015 an emphasis is given to the best possible pharmacological treatment of 22q11-2 Deletion-Syndrome related psychoses. We would like to present the case of a 23-year old Cypriot patient with 22q11.2 deletion syndrome who fulfilled criteria for treatment resistant schizophrenia (TRS). He was sequentially treated with aripiprazole, risperidone, olanzapine, haloperidol and a combination treatment with olanzapine and haloperidol. Clozapine was the only antipsychotic medication that has improved his condition.

Orthopaedic manifestations within the 22q11.2 Deletion syndrome: A systematic review

2017 ◽  
Vol 176 (10) ◽  
pp. 2104-2120 ◽  
Author(s):  
Jelle F. Homans ◽  
Isabel N. Tromp ◽  
Dino Colo ◽  
Tom P. C. Schlösser ◽  
Moyo C. Kruyt ◽  
...  
Keyword(s):  
Systematic Review ◽  
22Q11.2 Deletion Syndrome ◽  
Deletion Syndrome ◽  
22Q11.2 Deletion

Basal ganglia calcification and psychosis in 22q11.2 deletion syndrome

2005 ◽  
Vol 20 (8) ◽  
pp. 567-569 ◽  
Author(s):  
M. Sieberer ◽  
H. Haltenhof ◽  
B. Haubitz ◽  
B. Pabst ◽  
K. Miller ◽  
...  
Keyword(s):  
Basal Ganglia ◽  
Psychiatric Disorders ◽  
Psychiatric Symptoms ◽  
22Q11.2 Deletion Syndrome ◽  
Deletion Syndrome ◽  
Psychotic Symptoms ◽  
22Q11.2 Deletion ◽  
Basal Ganglia Calcification ◽  
Future Work

AbstractIntracerebral calcifications are a facultative symptom of hypoparathyreoidism in 22q11.2 deletion syndrome (22qDS). We describe a patient with 22qDS, basal ganglia calcification (BGC) and psychotic symptoms and discuss the etiological connection of BGC with psychiatric symptoms. Future work needs to determine the prevalence of BGC in 22qDS and psychiatric disorders.

Sign in / Sign up

Export Citation Format

Share Document